Remember meForgot password?
    Log in with Twitter

article imageOp-Ed: Medical marijuana is the elephant in the room across the world

By Robert Weller     Jul 7, 2014 in Health
Washington - Researchers are toiling around the clock to prove marijuana can help people suffering from a dozen diseases, including epilepsy, cancer and neuropathic pain.
In thousands of cases existing, legal products do not help them.
Washington state, which had been selling medical marijuana since 1998, begins selling recreational marijuana Tuesday. Colorado has been selling it since Jan. 1.
And no there have been no confirmed deaths or people turning into Fritos-munching zombies. One New York Times columnist freaked when she ate to large a dose of an edible.
It is known that marijuana has been used as a medicine for thousands of years, but American legislators, prodded to keep natural hemp out so that synthetics could replace them, effectively banned marijuana in laws passed in 1937 and 1938. Hemp and marijuana come from the same plant. Therefore industry could kill two birds with one stone.
Billions, perhaps trillions, have been spent enforcing anti-marijuana laws, cops employed and drug cartels enriched. Of course it also filled prisons, mostly with blacks. Now there is a giant industry that wants to keep it illegal.
The administration of President Barack Obama, who couldn’t legalize marijuana if he wanted to and he may well want to, has ordered federal law enforcement to ignore the use of weed by recreational users not in the drug or money laundering business.
So many states are voting on legalizing medical marijuana, and a few recreational marijuana, that it seems like a contest with who will the battle for the right to have same-sex marriages.
Last month, the Food and Drug Adminisration gave GW Pharmaceuticals permission for fast track testing and development Eipdiolex for the treatment of epilepsy-causing Dravet’s syndrome. Television viewers have seen families moving to Colorado, Washington and other states that allow medical marijuana to get the CBD-based drugs. CBD is not psychoactive.
“GW is focused on advancing the Epidiolex development program as rapidly as possible with the aim of addressing the significant unmet need in children suffering from Dravet syndrome. The granting of Fast Track designation, in addition to Epidiolex having already received orphan drug designation from the FDA, represents significant additional support toward this objective,” sad Justin Gover, GW’s CEO.
GW already sells Sativex in 11 countries, mostly in Europe to help patents live with the multiple sclerosis. More countries will soon authorize it.
This opinion article was written by an independent writer. The opinions and views expressed herein are those of the author and are not necessarily intended to reflect those of
More about Marijuana, Medical Marijuana, Weed, Drug war, Drug cartels
More news from
Latest News
Top News